157 results on '"severe asthma"'
Search Results
2. Identification of candidate genes and molecular mechanisms related to asthma progression using bioinformatics
3. Real-Life Response to Biologics in Severe Asthma with Nasal Polyposis: Insights from the Belgian Severe Asthma Registry
4. Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study
5. Neutralization of CX3CL1 Attenuates TGF-β-Induced Fibroblast Differentiation Through NF-κB Activation and Mitochondrial Dysfunction in Airway Fibrosis
6. Perceptions of sedentary behaviour in people with severe asthma: a qualitative study
7. Impact of biological therapies on clinical outcomes in patients with severe eosinophilic asthma with chronic rhinosinusitis: an observational study from Saudi Arabia
8. Tezepelumab for severe asthma: elevating current practice to recognize epithelial driven profiles
9. In mouse model of mixed granulocytic asthma with corticosteroid refractoriness, Bronchom mitigates airway hyperresponsiveness, inflammation and airway remodeling
10. Outcomes of biological therapy in patients with severe asthma with chronic rhinosinusitis in Saudi Arabia: patients with nasal polyps versus those without nasal polyps
11. Geographic and economic influences on benralizumab prescribing for severe asthma in Japan
12. Childhood severe asthma: relationship among asthma control scores, FeNO, spirometry and impulse oscillometry
13. A survey of severe asthma in Canada: results from the CASCADE practice reflective program
14. Aerobic physical training reduces severe asthma phenotype involving kinins pathway
15. Optimizing care for children with difficult-to-treat and severe asthma through specialist paediatric asthma centres: expert practical experience and advice
16. Long-term multicenter comparison shows equivalent efficacy of monoclonal antibodies in severe asthma therapy
17. Quality of life and work functionality in severe asthma patients: the impact of biological therapies
18. Patient education needs in severe asthma, a pilot study
19. Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational study
20. Accelerometer-derived sleep metrics in mild and difficult-to-treat asthma
21. Unraveling the Molecular Landscape of Neutrophil Extracellular Traps in Severe Asthma: Identification of Biomarkers and Molecular Clusters
22. Exploring Perceptions of Biologic Therapies: A Qualitative Study Among Canadians Living with Severe Asthma
23. Efficacy of Biologics in Patients with Allergic Severe Asthma, Overall and by Blood Eosinophil Count: A Literature Review
24. miR-146a-3p as a potential novel therapeutic by targeting MBD2 to mediate Th17 differentiation in Th17 predominant neutrophilic severe asthma
25. Severe Asthma Patients: Can We Really Wean Them off of Oral Corticosteroids
26. Updates in the Role of Biologics in Asthma
27. Factors influencing poor response to type 2 targeted therapies in severe asthma: a retrospective cohort study
28. Characterization and inhibition of inflammasome responses in severe and non-severe asthma
29. S100A alarmins and thymic stromal lymphopoietin (TSLP) regulation in severe asthma following bronchial thermoplasty
30. PRevalence of the Eosinophilic Phenotype Among SeveRE asthma patients in Lebanon: results of the PREPARE study
31. Severe asthma patient with secondary Citrobacter koseri abdominal infection: first case report and review of the literature
32. Long-term efficacy of anti-IL-4 receptor antibody in a patient with aspirin-exacerbated respiratory disease and IgG4-related disease
33. A prognosis prediction chromatin regulator signature for patients with severe asthma
34. Peripheral blood eosinophilia in adult asthmatic patients and its association with the severity of asthma
35. Geographical differences in the use of oral corticosteroids in patients with severe asthma in Spain: heat map based on existing databases analyses
36. Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials
37. Role of Bronchoscopy in the Diagnosis and Treatment of Severe Asthma
38. Efficacy of Biologics in Severe, Uncontrolled Asthma Stratified by Blood Eosinophil Count: A Systematic Review
39. The Comorbid Patient in the Spotlight: Efficacy of Benralizumab on Chronic Rhinosinusitis with Nasal Polyp Outcomes in Presence of Severe Asthma
40. “Adrenaline junkie”: a case report of repeated use of epinephrine
41. A Renewed Charter: Key Principles to Improve Patient Care in Severe Asthma
42. Impact of Biologic Therapy on the Small Airways Asthma Phenotype
43. Praxisrelevante Entwicklungen in der Lungenheilkunde
44. A Response to: Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab”
45. Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab”
46. A case of protracted eosinopenia after a single subcutaneous dose of benralizumab
47. Patient-reported outcome measures after 8 weeks of mepolizumab treatment and long-term outcomes in patients with severe asthma: an observational study
48. Severe asthma as the initial clinical manifestation of IgG4-related disease: a retrospective clinical study
49. The new era of add-on asthma treatments: where do we stand?
50. Prevalence of eosinophilic, atopic, and overlap phenotypes among patients with severe asthma in Saudi Arabia: a cross-sectional study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.